Onco Wiki / Bandera roja

Carcinoma de células escamosas del pene MSI-alto / dMMR — un subs...

Vista determinista de la entidad fuente YAML. La autoridad clínica sigue con los ID de fuente citados y estado de firma del revisor.

IDRF-PENILE-SCC-MSI-H-ACTIONABILITY
TipoSeñal de alerta
Situaciónreviewed 2026-07-11 | pending_clinical_signoff
EnfermedadesDIS-PENILE-SCC
FuentesSRC-EAU-PENILE-2024

Origen de la bandera roja

DefiniciónMSI-high / dMMR penile squamous cell carcinoma — an uncommon but described biomarker subset. Opens pembrolizumab (tissue-agnostic MSI-H/dMMR FDA approval, KEYNOTE-158/164 basket) as an alternative to cisplatin-based chemotherapy in metastatic/unresectable disease.
Dirección clínicaintensificar
Categoríahigh-risk-biology
Algoritmo de cambiosALGO-PENILE-SCC-1L

Lógica de activación

{
  "any_of": [
    {
      "finding": "msi_status",
      "value": "MSI-H"
    },
    {
      "finding": "dmmr_status",
      "value": "deficient"
    }
  ],
  "type": "biomarker"
}

Notas

STUB. Drafted for the DIS-PENILE-SCC Phase 1 authoring pass. MSI-H is rare in penile SCC and testing is not routine — this RF fires only when MSI/dMMR testing has actually been performed and returns positive. Mirrors RF-CRC-MSI-H-ACTIONABILITY's trigger/finding-key convention (finding: msi_status / dmmr_status) for consistency across the KB. Requires clinical co-lead signoff before publication (CHARTER §6.1; dev-mode-exempted for draft merge).

Utilizado por

Algoritmos

Indicación